Jan Storek

13.2k total citations · 1 hit paper
187 papers, 7.6k citations indexed

About

Jan Storek is a scholar working on Hematology, Immunology and Epidemiology. According to data from OpenAlex, Jan Storek has authored 187 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Hematology, 79 papers in Immunology and 49 papers in Epidemiology. Recurrent topics in Jan Storek's work include Hematopoietic Stem Cell Transplantation (111 papers), T-cell and B-cell Immunology (42 papers) and Cytomegalovirus and herpesvirus research (38 papers). Jan Storek is often cited by papers focused on Hematopoietic Stem Cell Transplantation (111 papers), T-cell and B-cell Immunology (42 papers) and Cytomegalovirus and herpesvirus research (38 papers). Jan Storek collaborates with scholars based in Canada, United States and Australia. Jan Storek's co-authors include Michael Boeckh, Hermann Einsele, Rainer Storb, Ronald E. Gress, David G. Maloney, Jo‐Anne H. Young, John R. Wingard, Tom Chiller, Kent A. Sepkowitz and Marcie Tomblyn and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Jan Storek

173 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

2009 1.1k citations Marcie Tomblyn, Tom Chiller et al. Biology of Blood and Marrow Transplantation profile →

Peers

Countries citing papers authored by Jan Storek

Since Specialization

Citations

This map shows the geographic impact of Jan Storek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Storek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Storek more than expected).

Fields of papers citing papers by Jan Storek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Storek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Storek. The network helps show where Jan Storek may publish in the future.

Co-authorship network of co-authors of Jan Storek

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Storek. A scholar is included among the top collaborators of Jan Storek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Storek. Jan Storek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Measuring Patient Preferences to Inform Clinical Trial Design: An Example in Rheumatoid Arthritis 2024 ·Patient ·Gillian Currie, Jan Storek, Karen V. MacDonald, Glen Hazlewood, Caylib Durand, John F. P. Bridges, Dianne Mosher, Deborah A. Marshall	0
2	Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic? 2023 ·Bone Marrow Transplantation ·Jan Storek, Julian Lindsay	2
3	Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy 2023 ·Bone Marrow Transplantation ·Gèrard Socié, Pere Barba, Arie Barlev, Jaime Sanz, Irene García‐Cadenas, Patrice Chevallier, Franca Fagioli, Norma Guzmán‐Becerra, Deepali Kumar, Per Ljungman, Arnaud Pigneux, Natalia Sadetsky, Lucrecia Yáñez, Mazyar Shadman, Jan Storek, (unknown), (unknown), Mohamad Mohty	9
4	Cumulative incidence of subsequent malignancy after allo-HCT conditioned with or without low-dose total body irradiation 2022 ·Blood Advances ·(unknown), Tasnima Abedin, S. Ali Naqvi, Hua Shen, Ahsan Chaudhry, (unknown), Mary Lynn Savoie, Andrew Daly, Mona Shafey, Peter Duggan, Jan Storek, Kareem Jamani	7
5	Toward optimization of cyclosporine concentration target to prevent acute graft‐versus‐host disease following myeloablative allogeneic stem cell transplant 2022 ·Clinical Transplantation ·(unknown), (unknown), Sunita Ghosh, Catherine Leyshon, Deonne Dersch‐Mills, Robert Puckrin, Peter Duggan, (unknown), Mary Lynn Savoie, Douglas A. Stewart, Jan Storek, Kareem Jamani	4
6	Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease 2022 ·Cytotherapy ·(unknown), Gaurav Tripathi, Poonam Dharmani‐Khan, (unknown), (unknown), (unknown), Robert Puckrin, (unknown), Kareem Jamani, Peter Duggan, Ahsan Chaudhry, Adam Bryant, Douglas A. Stewart, Faisal Khan, Jan Storek	2
7	Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation 2021 ·Transplantation and Cellular Therapy ·(unknown), (unknown), (unknown), Tyler Williamson, (unknown), Kareem Jamani, Ahsan Chaudhry, Mona Shafey, Víctor H. Jiménez‐Zepeda, Peter Duggan, Andrew Daly, Poonam Dharmani‐Khan, Faisal Khan, Jan Storek	15
8	Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low‐dose total body irradiation, and rabbit antithymocyte globulin 2020 ·Clinical Transplantation ·(unknown), (unknown), Tyler Williamson, Nicole L. Prokopishyn, Poonam Dharmani‐Khan, Faisal Khan, (unknown), Kareem Jamani, Peter Duggan, Andrew Daly, James A. Russell, Jan Storek	11
9	Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy 2019 ·Biology of Blood and Marrow Transplantation ·Steven A. Pergam, Janet A. Englund, Mini Kamboj, Hayley A. Gans, Jo‐Anne H. Young, Joshua A. Hill, Bipin N. Savani, Roy F. Chemaly, Sanjeet Dadwal, Jan Storek, Jeffery Duchin, Paul A. Carpenter	19
10	Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation 2019 ·Biology of Blood and Marrow Transplantation ·Jeffrey A. Cohen, Laura Baldassari, Harold Atkins, James D. Bowen, Christopher Bredeson, Paul A. Carpenter, John R. Corboy, Mark S. Freedman, Linda M. Griffith, Robert Lowsky, Navneet S. Majhail, Paolo A. Muraro, Richard A. Nash, Marcelo C. Pasquini, Stefanie Sarantopoulos, Bipin N. Savani, Jan Storek, Keith M. Sullivan, George E. Georges	72
11	Risk factors for post‐transplant lymphoproliferative disorder after Thymoglobulin‐conditioned hematopoietic cell transplantation 2017 ·Clinical Transplantation ·(unknown), (unknown), (unknown), Tyler Williamson, Raymond Tellier, Ahsan Chaudhry, Faisal Khan, (unknown), Víctor H. Jiménez‐Zepeda, Douglas A. Stewart, Andrew Daly, Jan Storek	21
12	Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in Thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with Thymoglobulin GVHD prophylaxis 2015 ·Bone Marrow Transplantation ·Andrew Lim, Jan Storek, (unknown), Marnie Collins, Mark Tacey, Tyler Williamson, Kylie D. Mason, (unknown), M. Ahsan Chaudhry, Jeffrey A. Russell, Andrew Daly, Jeff Szer, (unknown), David Ritchie	4
13	Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hematopoietic Cell Transplantation 2015 ·Biology of Blood and Marrow Transplantation ·Peter Podgorny, (unknown), Yiping Liu, Poonam Dharmani‐Khan, Joanne Luider, Iwona Auer-Grzesiak, Adnan Mansoor, Tyler Williamson, Alejandra Ugarte-Torres, Mette Hoegh-Petersen, Faisal Khan, Loree Larratt, Víctor H. Jiménez‐Zepeda, Douglas A. Stewart, James A. Russell, Andrew Daly, Jan Storek	16
14	Rabbit Anti–T Cell Globulin in Allogeneic Hematopoietic Cell Transplantation 2014 ·Biology of Blood and Marrow Transplantation ·Jan Storek, Mohamad Mohty, Jaap Jan Boelens	78
15	Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation 2011 ·Biology of Blood and Marrow Transplantation ·Abraham Guerrero, Stanley R. Riddell, Jan Storek, Terry Stevens‐Ayers, Barry E. Storer, John A. Zaia, Stephen J. Forman, Robert S. Negrin, Thomas R. Chauncey, William Bensinger, Michael Boeckh	22
16	Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective breakdown → 2009 ·Biology of Blood and Marrow Transplantation ·Marcie Tomblyn, Tom Chiller, Hermann Einsele, Ronald E. Gress, Kent A. Sepkowitz, Jan Storek, John R. Wingard, Jo‐Anne H. Young, Michael Boeckh	1149
17	Immunological reconstitution after hematopoietic cell transplantation – its relation to the contents of the graft 2008 ·Expert Opinion on Biological Therapy ·Jan Storek	47
18	High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant Regimen 2008 ·Biology of Blood and Marrow Transplantation ·Michelle Geddes, (unknown), (unknown), Diana Quinlan, M. Ahsan Chaudhry, Douglas A. Stewart, Mary Lynn Savoie, Nizar J. Bahlis, Christopher Brown, Jan Storek, Börje S. Andersson, James A. Russell	101
19	Interleukin-7 improves reconstitution of antiviral CD4 T cells 2005 ·Biology of Blood and Marrow Transplantation ·Hailing Lu, Zhuo Zhao, Tomáš Kalina, Hans‐Peter Kiem, Jan Storek	2
20	Recovery of Mononuclear Cell Subsets after Bone Marrow Transplantation: Overabundance of CD4 ⁺ CD8 ⁺ Dual-Positive T Cells Reminiscent of Ontogeny 1992 ·Journal of Hematotherapy ·Jan Storek, Stephen A. Ferrara, Carmen Rodrı́guez, Andrew Saxon	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact